Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity.

Bulteau, Anne-Laure; O'Neill, Heather A; Kennedy, Mary Claire; Ikeda-Saito, Masao; Isaya, Grazia; Szweda, Luke I · Science · 2004

basic_science · Level V

Where this comes from

Abstract

Numerous degenerative disorders are associated with elevated levels of prooxidants and declines in mitochondrial aconitase activity. Deficiency in the mitochondrial iron-binding protein frataxin results in diminished activity of various mitochondrial iron-sulfur proteins including aconitase. We found that aconitase can undergo reversible citrate-dependent modulation in activity in response to pro-oxidants. Frataxin interacted with aconitase in a citrate-dependent fashion, reduced the level of oxidant-induced inactivation, and converted inactive [3Fe-4S]1+ enzyme to the active [4Fe-4S]2+ form of the protein. Thus, frataxin is an iron chaperone protein that protects the aconitase [4Fe-4S]2+ cluster from disassembly and promotes enzyme reactivation.

Medical subject headings